Fmcna - Farmerville in Farmerville, Louisiana - Dialysis Center

Fmcna - Farmerville is a medicare approved dialysis facility center in Farmerville, Louisiana and it has 12 dialysis stations. It is located in Union county at 108 Hill St, Farmerville, LA, 71241. You can reach out to the office of Fmcna - Farmerville at (318) 368-3337. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Fmcna - Farmerville has the following ownership type - Profit. It was first certified by medicare in February, 2000. The medicare id for this facility is 192633 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameFmcna - Farmerville
Location108 Hill St, Farmerville, Louisiana
No. of Dialysis Stations 12
Medicare ID192633
Managed ByFresenius Medical Care
Ownership TypeProfit
Late Shifts No

Contact Information


108 Hill St, Farmerville, Louisiana, 71241
(318) 368-3337

News Archive

Early-life exposure to PCBs diminishes immune response to diphtheria and tetanus vaccinations: Study

Children exposed to polychlorinated biphenyls early in life later had a diminished immune response to diphtheria and tetanus vaccinations, according to a study published online June 20 ahead of print in the peer-reviewed journal Environmental Health Perspectives. This result suggests that PCB exposure during the first years of life, a critical period in immune system development, could undermine the effectiveness of childhood vaccinations and possibly impair immune system responses to infection.

Patients with mild heart failure more likely to benefit from cardiac resynchronization therapy with defibrillation

Patients with dyssynchronous yet viable ventricles are most likely to benefit from cardiac resynchronization therapy combined with defibrillation, concludes the latest analysis of the MADIT CRT trial.

New proteins help patients to get more accurate diagnosis of MS

A group of proteins identified by researchers at Stockholm's KTH Royal Institute of Technology could play a role in helping multiple sclerosis patients get more accurate diagnostics about the severity and progress of their disease.

Micromet to offer shares of common stock

Micromet, Inc. announced today that it intends, subject to market and other conditions, to offer shares of its common stock pursuant to an underwriting agreement with Piper Jaffray & Co. Piper Jaffray is acting as sole underwriter for this offering.

Read more Medical News

› Verified 7 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Fmcna - Farmerville from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1194837963
Organization NameFmc Farmerville Dialysis
Doing Business AsBio-medical Applications Of Louisiana, Llc
Address108 W Hill St Farmerville, Louisiana, 71241
Phone Number(318) 368-3337

News Archive

Early-life exposure to PCBs diminishes immune response to diphtheria and tetanus vaccinations: Study

Children exposed to polychlorinated biphenyls early in life later had a diminished immune response to diphtheria and tetanus vaccinations, according to a study published online June 20 ahead of print in the peer-reviewed journal Environmental Health Perspectives. This result suggests that PCB exposure during the first years of life, a critical period in immune system development, could undermine the effectiveness of childhood vaccinations and possibly impair immune system responses to infection.

Patients with mild heart failure more likely to benefit from cardiac resynchronization therapy with defibrillation

Patients with dyssynchronous yet viable ventricles are most likely to benefit from cardiac resynchronization therapy combined with defibrillation, concludes the latest analysis of the MADIT CRT trial.

New proteins help patients to get more accurate diagnosis of MS

A group of proteins identified by researchers at Stockholm's KTH Royal Institute of Technology could play a role in helping multiple sclerosis patients get more accurate diagnostics about the severity and progress of their disease.

Micromet to offer shares of common stock

Micromet, Inc. announced today that it intends, subject to market and other conditions, to offer shares of its common stock pursuant to an underwriting agreement with Piper Jaffray & Co. Piper Jaffray is acting as sole underwriter for this offering.

Read more Medical News

› Verified 7 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data9

News Archive

Early-life exposure to PCBs diminishes immune response to diphtheria and tetanus vaccinations: Study

Children exposed to polychlorinated biphenyls early in life later had a diminished immune response to diphtheria and tetanus vaccinations, according to a study published online June 20 ahead of print in the peer-reviewed journal Environmental Health Perspectives. This result suggests that PCB exposure during the first years of life, a critical period in immune system development, could undermine the effectiveness of childhood vaccinations and possibly impair immune system responses to infection.

Patients with mild heart failure more likely to benefit from cardiac resynchronization therapy with defibrillation

Patients with dyssynchronous yet viable ventricles are most likely to benefit from cardiac resynchronization therapy combined with defibrillation, concludes the latest analysis of the MADIT CRT trial.

New proteins help patients to get more accurate diagnosis of MS

A group of proteins identified by researchers at Stockholm's KTH Royal Institute of Technology could play a role in helping multiple sclerosis patients get more accurate diagnostics about the severity and progress of their disease.

Micromet to offer shares of common stock

Micromet, Inc. announced today that it intends, subject to market and other conditions, to offer shares of its common stock pursuant to an underwriting agreement with Piper Jaffray & Co. Piper Jaffray is acting as sole underwriter for this offering.

Read more Medical News

› Verified 7 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center27
    Adult patient months included in Kt/V greater than or equal to 1.2204
    Percentage of adult patients getting regular hemodialysis at the center99
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Early-life exposure to PCBs diminishes immune response to diphtheria and tetanus vaccinations: Study

    Children exposed to polychlorinated biphenyls early in life later had a diminished immune response to diphtheria and tetanus vaccinations, according to a study published online June 20 ahead of print in the peer-reviewed journal Environmental Health Perspectives. This result suggests that PCB exposure during the first years of life, a critical period in immune system development, could undermine the effectiveness of childhood vaccinations and possibly impair immune system responses to infection.

    Patients with mild heart failure more likely to benefit from cardiac resynchronization therapy with defibrillation

    Patients with dyssynchronous yet viable ventricles are most likely to benefit from cardiac resynchronization therapy combined with defibrillation, concludes the latest analysis of the MADIT CRT trial.

    New proteins help patients to get more accurate diagnosis of MS

    A group of proteins identified by researchers at Stockholm's KTH Royal Institute of Technology could play a role in helping multiple sclerosis patients get more accurate diagnostics about the severity and progress of their disease.

    Micromet to offer shares of common stock

    Micromet, Inc. announced today that it intends, subject to market and other conditions, to offer shares of its common stock pursuant to an underwriting agreement with Piper Jaffray & Co. Piper Jaffray is acting as sole underwriter for this offering.

    Read more Medical News

    › Verified 7 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Fmcna - Farmerville with elevated calcium levels.

Patients with hypercalcemia27
Hypercalcemia patient months205
Patients with Serumphosphor27
Patients with Serumphosphor less than 3.5 mg/dL10
Patients with Serumphosphor from 3.5 to 4.5 mg/dL30
Patients with Serumphosphor from 4.6 to 5.5 mg/dL28
Patients with Serumphosphor from 5.6 to 7 mg/dL24
Patients with Serumphosphor greater than 7 mg/dL9

News Archive

Early-life exposure to PCBs diminishes immune response to diphtheria and tetanus vaccinations: Study

Children exposed to polychlorinated biphenyls early in life later had a diminished immune response to diphtheria and tetanus vaccinations, according to a study published online June 20 ahead of print in the peer-reviewed journal Environmental Health Perspectives. This result suggests that PCB exposure during the first years of life, a critical period in immune system development, could undermine the effectiveness of childhood vaccinations and possibly impair immune system responses to infection.

Patients with mild heart failure more likely to benefit from cardiac resynchronization therapy with defibrillation

Patients with dyssynchronous yet viable ventricles are most likely to benefit from cardiac resynchronization therapy combined with defibrillation, concludes the latest analysis of the MADIT CRT trial.

New proteins help patients to get more accurate diagnosis of MS

A group of proteins identified by researchers at Stockholm's KTH Royal Institute of Technology could play a role in helping multiple sclerosis patients get more accurate diagnostics about the severity and progress of their disease.

Micromet to offer shares of common stock

Micromet, Inc. announced today that it intends, subject to market and other conditions, to offer shares of its common stock pursuant to an underwriting agreement with Piper Jaffray & Co. Piper Jaffray is acting as sole underwriter for this offering.

Read more Medical News

› Verified 7 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 22
Patient months included in arterial venous fistula and catheter summaries 162
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment81
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer4

News Archive

Early-life exposure to PCBs diminishes immune response to diphtheria and tetanus vaccinations: Study

Children exposed to polychlorinated biphenyls early in life later had a diminished immune response to diphtheria and tetanus vaccinations, according to a study published online June 20 ahead of print in the peer-reviewed journal Environmental Health Perspectives. This result suggests that PCB exposure during the first years of life, a critical period in immune system development, could undermine the effectiveness of childhood vaccinations and possibly impair immune system responses to infection.

Patients with mild heart failure more likely to benefit from cardiac resynchronization therapy with defibrillation

Patients with dyssynchronous yet viable ventricles are most likely to benefit from cardiac resynchronization therapy combined with defibrillation, concludes the latest analysis of the MADIT CRT trial.

New proteins help patients to get more accurate diagnosis of MS

A group of proteins identified by researchers at Stockholm's KTH Royal Institute of Technology could play a role in helping multiple sclerosis patients get more accurate diagnostics about the severity and progress of their disease.

Micromet to offer shares of common stock

Micromet, Inc. announced today that it intends, subject to market and other conditions, to offer shares of its common stock pursuant to an underwriting agreement with Piper Jaffray & Co. Piper Jaffray is acting as sole underwriter for this offering.

Read more Medical News

› Verified 7 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary25
Hospitalization Rate in facility172.4 (As Expected)
Hospitalization Rate: Upper Confidence Limit370.8
Hospitalization Rate: Lower Confidence Limit85.2

News Archive

Early-life exposure to PCBs diminishes immune response to diphtheria and tetanus vaccinations: Study

Children exposed to polychlorinated biphenyls early in life later had a diminished immune response to diphtheria and tetanus vaccinations, according to a study published online June 20 ahead of print in the peer-reviewed journal Environmental Health Perspectives. This result suggests that PCB exposure during the first years of life, a critical period in immune system development, could undermine the effectiveness of childhood vaccinations and possibly impair immune system responses to infection.

Patients with mild heart failure more likely to benefit from cardiac resynchronization therapy with defibrillation

Patients with dyssynchronous yet viable ventricles are most likely to benefit from cardiac resynchronization therapy combined with defibrillation, concludes the latest analysis of the MADIT CRT trial.

New proteins help patients to get more accurate diagnosis of MS

A group of proteins identified by researchers at Stockholm's KTH Royal Institute of Technology could play a role in helping multiple sclerosis patients get more accurate diagnostics about the severity and progress of their disease.

Micromet to offer shares of common stock

Micromet, Inc. announced today that it intends, subject to market and other conditions, to offer shares of its common stock pursuant to an underwriting agreement with Piper Jaffray & Co. Piper Jaffray is acting as sole underwriter for this offering.

Read more Medical News

› Verified 7 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Fmcna - Farmerville were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility36.1 (As Expected)
Readmission Rate: Upper Confidence Limit55.9
Readmission Rate: Lower Confidence Limit19.9

News Archive

Early-life exposure to PCBs diminishes immune response to diphtheria and tetanus vaccinations: Study

Children exposed to polychlorinated biphenyls early in life later had a diminished immune response to diphtheria and tetanus vaccinations, according to a study published online June 20 ahead of print in the peer-reviewed journal Environmental Health Perspectives. This result suggests that PCB exposure during the first years of life, a critical period in immune system development, could undermine the effectiveness of childhood vaccinations and possibly impair immune system responses to infection.

Patients with mild heart failure more likely to benefit from cardiac resynchronization therapy with defibrillation

Patients with dyssynchronous yet viable ventricles are most likely to benefit from cardiac resynchronization therapy combined with defibrillation, concludes the latest analysis of the MADIT CRT trial.

New proteins help patients to get more accurate diagnosis of MS

A group of proteins identified by researchers at Stockholm's KTH Royal Institute of Technology could play a role in helping multiple sclerosis patients get more accurate diagnostics about the severity and progress of their disease.

Micromet to offer shares of common stock

Micromet, Inc. announced today that it intends, subject to market and other conditions, to offer shares of its common stock pursuant to an underwriting agreement with Piper Jaffray & Co. Piper Jaffray is acting as sole underwriter for this offering.

Read more Medical News

› Verified 7 days ago